The biopharmaceutical industry includes companies specializing in researching, developing, and commercializing therapies and tests at a molecular level. Texas hosts a variety of such companies that innovate in areas from prenatal and oncological testing, organ health assessment, to chronic kidney disease and cancer treatments. With the growing emphasis on personalized healthcare, the future of this industry in Texas seems promising.


Top 19 biopharmaceutical companies in Texas

1. Natera

  • Website: natera.com
  • Headquarters: Austin, Texas, United States
  • Founded: 2004
  • Headcount: 1001-5000
  • Latest funding type: Post Ipo Equity
  • LinkedIn

Natera is a global leader in cfDNA testing, offering noninvasive tests to measure fetal, tumor, or donor DNA at the molecular level. Their services include prenatal testing, oncology testing, and organ health assessment. They provide healthcare professionals and patients with valuable information to make more personalized healthcare decisions.


2. Reata Pharmaceuticals, Inc.

  • Website: reatapharma.com
  • Headquarters: Plano, Texas, United States
  • Founded: 2002
  • Headcount: 201-500
  • Latest funding type: Post Ipo Equity
  • LinkedIn

Reata Pharmaceuticals is a biopharmaceutical company focused on discovering, developing, and commercializing innovative therapies for patients with serious and life-threatening diseases. They specialize in developing drugs for chronic kidney diseases, such as autosomal dominant polycystic kidney disease and diabetic chronic kidney disease. Their investigational drug, bardoxolone methyl, shows promising results in improving kidney function. Safety and efficacy have not been established yet.


3. Molecular Templates

  • Website: mtem.com
  • Headquarters: Austin, Texas, United States
  • Founded: 2001
  • Headcount: 201-500
  • Latest funding type: Post Ipo Equity
  • LinkedIn

Molecular Templates is a clinical-stage biopharmaceutical company specializing in the discovery and development of engineered toxin bodies (ETBs), a novel class of therapeutics. Their pipeline consists of ETBs targeting important cancer receptors, currently in clinical trials, with the aim of providing significant benefits to patients.


4. Lexicon Pharmaceuticals, Inc.

  • Website: lexpharma.com
  • Headquarters: The Woodlands, Texas, United States
  • Founded: 1995
  • Headcount: 51-200
  • Latest funding type: Post Ipo Equity
  • LinkedIn

Lexicon Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to the development of groundbreaking treatments for human diseases. Through their unique gene science approach, they aim to bring innovative therapies to the market. Their passion and dedication are driven by the patients they aim to serve.


5. iBio, Inc.

  • Website: ibioinc.com
  • Headquarters: Bryan, Texas, United States
  • Founded: 2008
  • Headcount: 51-200
  • Latest funding type: Post Ipo Equity
  • LinkedIn

iBio, Inc. is a pioneering biotechnology and CDMO (Contract Development and Manufacturing Organization) company. They specialize in AI-Powered Precision Antibody Therapeutics and have a strong focus on research and development. With headquarters in Bryan, Texas and a research facility in San Diego, California, iBio offers innovative solutions in the field of biotechnology.


6. Shattuck Labs

  • Website: shattucklabs.com
  • Headquarters: Austin, Texas, United States
  • Founded: 2016
  • Headcount: 51-200
  • Latest funding type: Ipo
  • LinkedIn

Shattuck Labs is a biotech company that specializes in the development of bi-functional fusion proteins. They utilize their proprietary ARC (Agonist Redirected Checkpoint) technology to target and unlock the TNFr superfamily in a unique fashion while simultaneously blocking an immune checkpoint. Their portfolio of over 400 fusion proteins includes therapies that target clinically validated as well as emerging pathways.


7. G-con

  • Website: gconbio.com
  • Headquarters: College Station, Texas, United States
  • Founded: 2009
  • Headcount: 51-200
  • Latest funding type: Acquired
  • LinkedIn

G-CON is a global biocapacity provider enabling the speed and delivery of manufacturing infrastructure for biopharmaceutical products. They deliver complete, prefabricated biopharmaceutical cleanroom environments for small labs to commercial scale production platforms.


8. Orano Med

  • Website: oranomed.com
  • Headquarters: Plano, Texas, United States
  • Founded: 2009
  • Headcount: 51-200
  • LinkedIn

Orano Med seeks to develop a new generation of targeted therapies against cancer using lead-212 (212Pb), a rare alpha-emitting radioisotope.


9. ReCode Therapeutics

  • Website: recodetx.com
  • Headquarters: Menlo Park, Texas, United States
  • Founded: 2015
  • Headcount: 11-50
  • Latest funding type: Series Unknown
  • LinkedIn

ReCode Therapeutics is a genetic medicine company that aims to overcome the limitations of current delivery systems to provide disease-modifying therapeutics for people with rare diseases.


10. Avance Biosciences, Inc.

Avance Bio provides innovative solutions in the field of biotechnology. They offer a wide range of services aimed at accelerating drug discovery and development processes. With advanced technologies and expertise, they enable pharmaceutical companies to revolutionize their research and improve their success rates.


11. Base Pair Biotechnologies, Inc.

  • Website: basepairbio.com
  • Headquarters: Pearland, Texas, United States
  • Founded: 2011
  • Headcount: 11-50
  • Latest funding type: Series A
  • LinkedIn

Base Pair is a biotechnology company that specializes in the development and application of aptamers. Their proprietary selection algorithms and characterization techniques enable them to simultaneously select aptamers for multiple targets. Base Pair offers a range of aptamer applications including drug discovery, therapeutic development, drug delivery, and biomarker detection.


12. Salarius Pharmaceuticals

  • Website: salariuspharma.com
  • Headquarters: Houston, Texas, United States
  • Founded: 2011
  • Headcount: 11-50
  • Latest funding type: Post Ipo Equity
  • LinkedIn

Salarius Pharmaceuticals is a clinical-stage biopharmaceutical company specializing in the development of therapies for cancer patients. They focus on addressing dysregulated gene expression in cancer cells through targeted protein inhibitors (TPIs) and targeted protein degraders (TPDs). With their drugs, such as seclidemstat (SP-2577) and SP-3164, they aim to positively impact the lives of patients with solid or hematologic cancers like leukemias and lymphomas.


13. Plus Therapeutics, Inc.

Plus Therapeutics is a biotech company that specializes in developing and delivering targeted radiotherapeutics for the treatment of rare and difficult-to-treat cancers. Their innovative approach involves encapsulating radiation particles, such as Rhenium, into nanoliposomes and administering them directly to tumor sites, potentially preserving normal cell and tissue functioning.


14. Genprex, Inc.

  • Website: genprex.com
  • Headquarters: Austin, Texas, United States
  • Founded: 2009
  • Headcount: 11-50
  • Latest funding type: Post Ipo Equity
  • LinkedIn

Genprex is a biotechnology company specializing in developing gene therapies for patients with cancer. Their innovative treatments aim to target and treat specific types of cancer cells, offering personalized and effective solutions. With a focus on research and development, Genprex strives to revolutionize cancer treatment and improve patient outcomes.


15. Mirna Therapeutics, Inc.

  • Website: mirnarx.com
  • Headquarters: Austin, Texas, United States
  • Founded: 2007
  • Headcount: 11-50
  • LinkedIn

MirnaRx is a pharmaceutical company that focuses on developing RNA-based therapeutics for various diseases.


16. Vyripharm Enterprises, Inc.

Vyripharm Enterprises offers disruptive emerging biopharmaceutical and biotechnology innovations with a focus on improving public health and safety through cutting-edge diagnostics and therapeutics.


17. Cao Pharmaceuticals Inc.

Cao Pharmaceuticals Inc. is a biotech company that uses nature's best anti-cancer compound to develop cancer drugs.


18. Pure MHC, LLC

Pure MHC, LLC is a discovery and development company with platform technology and expertise in disease-specific target identification and validation, as well as immunotherapeutic drug development for cancer, infectious, and autoimmune diseases.


19. Tvardi Therapeutics

Tvardi Therapeutics is a private, clinical stage biotechnology company that aims to develop novel inhibitors of STAT3, a molecule implicated in the initiation and progression of cancer and fibrosis.


Want to find more biopharmaceutical companies?


If you want to find more companies that offer state-of-the-art therapies and innovative molecular tests you can do so with Inven. This list was built with Inven and there are hundreds of companies like these globally.


With Inven you'll also get to know the company's:


  • Ownership: Which of these are private equity backed? Which are family-owned?
  • Contact data: Who are the owners and CEO's? What are their emails and phone numbers?
  • Financials: How do these companies perform financially? What are their revenues and profit margins?

...and a lot more!